论文部分内容阅读
目的:对心脏疾病妇女围产期发生心脏不良事件的相关因素进行分析,为其临床研究提供依据。方法:选择86例入住该院患有心脏疾病的围产期妇女作为研究对象,根据其是否发生心脏不良事件分为不良事件组20例(23.26%)与无不良事件组66例(76.74%),采用回顾性方法记录相关信息。筛选出影响心脏不良事件发生的相关因素,应用Logistic回归对心脏不良事件发生因素进行回归分析。结果:单因素分析发现年龄、重度妊娠期高血压疾病、深静脉血栓、肺动脉高压、美国纽约心脏病学会(NYHA)分级(>Ⅰ级)、左心室射血分数(LVEF)与心脏不良事件的发生相关,差异有统计学意义(P<0.05)。存在深静脉血栓、肺动脉高压,NYHA分级>Ⅰ级,LVEF是心脏疾病妇女围产期发生心脏不良事件的独立危险因素,差异有统计学意义(P<0.05)。结论:多种因素影响心脏疾病孕妇围产期心脏不良事件的发生,存在深静脉血栓、肺动脉高压,NYHA分级>Ⅰ级,LVEF是心脏不良事件发生的独立危险因素,对这些危险因素需要进行必要的干预,对增加心脏病孕妇围产期血流动力学稳定性及改善患者预后有积极作用。
Objective: To analyze the related factors of perinatal cardiac events in women with heart diseases and provide the basis for their clinical research. Methods: A total of 86 perinatal women admitted to our hospital with heart disease were enrolled in this study. According to their adverse cardiac events, 20 patients (23.26%) and 66 patients (76.74%) had adverse events. , Using a retrospective method to record the relevant information. Screening out the factors that affect the occurrence of cardiac adverse events, using Logistic regression regression analysis of cardiac adverse events. Results: Univariate analysis found that age, severe gestational hypertension, deep venous thrombosis, pulmonary hypertension, New York Heart Association (NYHA) grading (> I grade), left ventricular ejection fraction (LVEF) and cardiac adverse events Related, the difference was statistically significant (P <0.05). There was deep venous thrombosis, pulmonary hypertension, NYHA classification> grade I, and LVEF was an independent risk factor for perinatal cardiac events in women with heart disease. The difference was statistically significant (P <0.05). CONCLUSIONS: Various factors affect the occurrence of perinatal cardiac events in pregnant women with heart disease. There are deep venous thrombosis, pulmonary hypertension, NYHA classification> Ⅰ grade. LVEF is an independent risk factor for cardiac adverse events. Necessary for these risk factors The intervention has a positive effect on increasing perinatal hemodynamic stability and improving the prognosis of patients with heart disease.